OrthoPediatrics Corp. (NASDAQ:KIDS) Receives $24.00 Consensus PT from Brokerages

OrthoPediatrics Corp. (NASDAQ:KIDS) has been assigned an average recommendation of “Moderate Buy” from the ten research firms that are currently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and eight have issued a buy rating on the company. The average 1 year target price among analysts that have issued ratings on the stock in the last year is $24.00.

A number of equities analysts recently weighed in on the stock. BTIG Research reissued a “buy” rating and set a $23.00 target price on shares of OrthoPediatrics in a research note on Wednesday, October 29th. Citigroup reiterated an “outperform” rating on shares of OrthoPediatrics in a report on Friday, October 10th. Stifel Nicolaus dropped their price objective on OrthoPediatrics from $32.00 to $20.00 and set a “buy” rating on the stock in a research note on Friday, October 10th. Truist Financial set a $18.00 target price on OrthoPediatrics in a research note on Friday, October 10th. Finally, Piper Sandler lowered their target price on OrthoPediatrics from $30.00 to $22.00 and set an “overweight” rating for the company in a report on Friday, October 10th.

Institutional Investors Weigh In On OrthoPediatrics

Several hedge funds and other institutional investors have recently made changes to their positions in KIDS. Prosight Management LP raised its position in OrthoPediatrics by 319.2% in the 3rd quarter. Prosight Management LP now owns 308,707 shares of the company’s stock valued at $5,720,000 after buying an additional 235,060 shares during the last quarter. Millennium Management LLC raised its holdings in shares of OrthoPediatrics by 55.3% in the first quarter. Millennium Management LLC now owns 656,578 shares of the company’s stock valued at $16,172,000 after purchasing an additional 233,873 shares during the last quarter. Harbor Capital Advisors Inc. lifted its position in shares of OrthoPediatrics by 116.5% during the second quarter. Harbor Capital Advisors Inc. now owns 333,959 shares of the company’s stock valued at $7,173,000 after purchasing an additional 179,733 shares in the last quarter. Deerfield Management Company L.P. boosted its holdings in OrthoPediatrics by 1,153.4% during the third quarter. Deerfield Management Company L.P. now owns 194,109 shares of the company’s stock worth $3,597,000 after purchasing an additional 178,623 shares during the last quarter. Finally, Goldman Sachs Group Inc. grew its position in OrthoPediatrics by 112.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 200,439 shares of the company’s stock worth $4,937,000 after purchasing an additional 106,041 shares in the last quarter. 69.05% of the stock is owned by institutional investors.

OrthoPediatrics Price Performance

Shares of KIDS stock opened at $18.71 on Tuesday. The business has a fifty day simple moving average of $17.83 and a 200 day simple moving average of $19.05. The company has a market cap of $469.25 million, a P/E ratio of -9.59 and a beta of 1.09. The company has a quick ratio of 3.52, a current ratio of 7.40 and a debt-to-equity ratio of 0.28. OrthoPediatrics has a twelve month low of $15.28 and a twelve month high of $27.60.

OrthoPediatrics (NASDAQ:KIDS) last issued its earnings results on Tuesday, October 28th. The company reported ($0.24) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.26) by $0.02. OrthoPediatrics had a negative net margin of 20.06% and a negative return on equity of 6.86%. The firm had revenue of $61.25 million for the quarter, compared to analyst estimates of $63.63 million. On average, sell-side analysts forecast that OrthoPediatrics will post -0.93 EPS for the current fiscal year.

About OrthoPediatrics

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.